Evidence map›Paper›PMID 37590217›Full record

ArticlePloS one2023

The impact of COVID-19 on maternal death and fetal death, a cohort study in Brazil.

Ana Paula Brioschi Dos Santos, Creuza Rachel Vicente, João Paulo Cola, Luana Fiengo Tanaka, Juliana Rodrigues Tovar Garbin, Larissa Soares Dell'Antonio, Cristiano Soares da Silva Dell'Antonio, Angelica Espinosa Miranda

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Changes in Placentas of Pregnant Women Infected with COVID-19.International journal of molecular sciences · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Ana Paula Brioschi Dos SantosPrograma de Pós-Graduação em Saúde Coletiva, Universidade Federal do Espírito Santo, Vitória, ES, Brasil.ORCID 0000-0002-9701-0314
Creuza Rachel VicenteDepartamento de Medicina, Programa de Pós-Graduação em Doenças Infecciosas, Universidade Federal do Espírito Santo, Vitória, ES, Brasil.
João Paulo ColaPrograma de Pós-Graduação em Saúde Coletiva, Universidade Federal do Espírito Santo, Vitória, ES, Brasil.ORCID 0000-0003-4972-4686
Luana Fiengo TanakaDepartment of Sport and Health Sciences, Technische Universität München, Munich, Germany.ORCID 0000-0002-2086-7491
Juliana Rodrigues Tovar GarbinPrograma de Pós-Graduação em Saúde Coletiva, Universidade Federal do Espírito Santo, Vitória, ES, Brasil.
Larissa Soares Dell'AntonioNúcleo Especial de Vigilância Epidemiológica, Secretaria de Estado da Saúde do Espírito Santo, Vitória, ES, Brasil.
Cristiano Soares da Silva Dell'AntonioNúcleo Especial de Vigilância Epidemiológica, Secretaria de Estado da Saúde do Espírito Santo, Vitória, ES, Brasil.ORCID 0000-0001-6568-1300
Angelica Espinosa MirandaPrograma de Pós-Graduação em Saúde Coletiva, Universidade Federal do Espírito Santo, Vitória, ES, Brasil.
Universidade Federal do Espírito Santo · BRSecretaria da Saúde · BRTechnical University of Munich · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe study aimed to evaluate the risk of maternal death and fetal death among pregnant women infected with SARS-CoV-2.

methodsThis is a retrospective cohort study among pregnant women with secondary data from the National Live Births System (Sistema Nacional de Nascidos Vivos), National Mortality System (Sistema Nacional de Mortalidade), and e-SUS Health Surveillance System (Sistema e-SUS Vigilância em Saúde). Pregnant women confirmed for COVID-19 had positive RT-PCR between March 2020 and May 2021, pregnant women without COVID-19 were those without notification for disease. Maternal death, fetal death, and stillbirth were assessed as primary outcomes.

resultsWe included 68,673 pregnant women not notified as suspected of COVID-19 and 1,386 with a confirmed diagnosis of COVID-19. Among pregnant women with COVID-19, 1013 (73.0%) were aged 20 to 34 years, 655 (47.2%) were brown, 907 (65.4%) had ≥ 8 years of education, in the third trimester of pregnancy (41.5%), undergoing cesarean section (64.5%). In adjusted analyses, COVID-19 in pregnancy had a higher risk of maternal death (relative risk [RR] 18.73-95% confidence interval [95%CI] 11.07-31.69), fetal death/stillbirth (RR 1.96-95%CI 1.18-3.25), preterm birth [RR 1.18-95%CI 1.01-1.39], cesarean delivery (RR 1.07-95%CI 1.02-1.11), and cesarean delivery occurring before the onset of labor (RR 1.33-95%CI 1.23-1.44).

conclusionCOVID-19 may contribute to unfavorable pregnancy outcomes. Results showed that pregnant women infected with SARS-CoV-2 had a higher risk of maternal death, fetal death/stillbirth, preterm birth, cesarean delivery, and cesarean section occurring before the onset of labor.

Indexed as

COVID-19Maternal DeathPremature BirthBrazilCesarean SectionCohort StudiesFemaleHumansInfant, NewbornPregnancyRetrospective StudiesSARS-CoV-2Stillbirth

Identifiers

PMID37590217
PMCPMC10434867
OpenAlexW4385945055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.